ELV vs RGEN · P/E 18, rev $199.13B vs P/E 143, rev $204.1M
Elevance Health Inc (ELV) versus Repligen Corporation (RGEN) — a side-by-side from cached financials, not a winner call.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Repligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Latest reported RGEN revenue for 2026-06-30 was $204.1M. Net income was $5.0M. Revenue was up 5.1% from 2026-03-31 to 2026-06-30. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
Not investment advice. Open the ELV and RGEN stock pages for the full models.
Not investment advice.